Showing results (161-170 of 196) with videos related to

Sort By:
Pageof 20
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|August 18, 2015
Virus-Induced Type I Interferon Deteriorates Control of Systemic Pseudomonas Aeruginosa InfectionKatja Merches, Vishal Khairnar, Torben Knuschke, et al.
Inflammatory Bowel Diseases|May 29, 2015
Chronological Order of Appearance of Extraintestinal Manifestations Relative to the Time of IBD Diagnosis in the Swiss Inflammatory Bowel Disease CohortStephan R Vavricka, Gerhard Rogler, Claudine Gantenbein, et al.
Nature Communications|December 4, 2014
The antimicrobial peptide LL37 is a T-cell autoantigen in psoriasisRoberto Lande, Elisabetta Botti, Camilla Jandus, et al.
The New England Journal of Medicine|December 22, 2021
Trial of Spesolimab for Generalized Pustular PsoriasisHervé Bachelez, Siew-Eng Choon, Slaheddine Marrakchi, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|December 29, 2023
Consistency of convolutional neural networks in dermoscopic melanoma recognition: A prospective real-world study about the pitfalls of augmented intelligenceE V Goessinger, S E Cerminara, A M Mueller, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|December 12, 2023
Sex differences in adverse events from systemic treatments for psoriasis: A decade of insights from the Swiss Psoriasis Registry (SDNTT)Fabio Verardi, Lara Valeska Maul, Kim Borsky, et al.
Journal of Psoriasis and Psoriatic Arthritis|September 19, 2024
Predicting Psoriatic Arthritis in Psoriasis Patients - A Swiss Registry StudyMia-Louise Nielsen, Troels C Petersen, Lara Valeska Maul, et al.
Dermatology (Basel, Switzerland)|January 20, 2017
Superiority in Quality of Life Improvement of Biologics over Conventional Systemic Drugs in a Swiss Real-Life Psoriasis RegistryPierre Jungo, Julia-Tatjana Maul, Vahid Djamei, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|September 28, 2023
Position statement of the EADV Artificial Intelligence (AI) Task Force on AI-assisted smartphone apps and web-based services for skin diseaseTobias E Sangers, Harald Kittler, Andreas Blum, et al.
Pageof 20